4//SEC Filing
Katz Richard D 4
Accession 0001171843-18-002408
CIK 0001105533other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 9:48 AM ET
Size
4.9 KB
Accession
0001171843-18-002408
Insider Transaction Report
Form 4
Katz Richard D
VP & Chief Financial Officer
Transactions
- Award
Common Stock
2018-03-28+22,629→ 32,326 total
Footnotes (1)
- [F1]The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 11,315 shares on June 15, 2018, and with respect to the remaining 11,314 shares on December 14, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.
Documents
Issuer
ARGOS THERAPEUTICS INC
CIK 0001105533
Entity typeother
Related Parties
1- filerCIK 0001293577
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 9:48 AM ET
- Size
- 4.9 KB